ARDT — Ardent Health Partners, LLC

Summary of Ardent Health Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $1.6 billion, up 7% year-over-year.
• Adjusted EBITDA: $124 million, a 26% increase, with a margin expansion of 110 basis points to 7.7%.
• Adjusted Admissions: Increased by 2%, aligning with the company's guidance range of 1.5% to 2.5%.
• Total Surgeries: Grew by 1.2%, with outpatient surgery growth at 1.7%.
• Labor Costs: Salaries, wages, and benefits per adjusted admission decreased by 1.4%, while supply expenses per adjusted admission grew modestly by 1.7%.
• Cash Position: Ended the quarter with $610 million in cash and $1.1 billion in total debt, resulting in a net leverage ratio of 1.0x.

2. Strategic Updates and Business Highlights

• IMPACT Program: Continued progress with expected savings of $55 million in 2026. Significant reductions in contract labor expenses (down over 40% to $15 million) and improved supply chain efficiencies were highlighted.
• Capacity IQ Strategy: Focused on surgeon recruitment and productivity to manage capacity and demand effectively.
• Outpatient Growth: Opened four urgent care centers in Q1 and plans to open additional facilities throughout the year.
• AI and Digital Tools: Implementing an AI-assisted virtual care platform across patient rooms to enhance operational efficiency and patient safety.

3. Forward Guidance and Outlook

• The company reaffirmed its full-year financial guidance for revenue and adjusted EBITDA, maintaining confidence despite early-year challenges.
• Anticipated modest EBITDA growth in Q2, driven by throughput improvements from the IMPACT program.
• Expected moderation in professional fee growth rates in the back half of the year.

4. Bad News, Challenges, or Points of Concern

• Volume Trends: Total admissions decreased by 1.1%, attributed to seasonal impacts from weather and a lighter flu season.
• Payer Mix: Slightly weaker performance in core commercial volumes, potentially influenced by macroeconomic conditions.
• Professional Fees: Increased by 100 basis points as a percentage of revenue, with expectations for continued pressure in the near term.
• Denials and Bad Debt: While stable, the company is closely monitoring payer denials and the potential for increased bad debt due to changes in patient behavior and coverage.

5. Notable Q&A Insights

• EBITDA Progression: Management indicated Q2 and Q3 might be more comparable in performance, with a modest step-up expected from Q1.
• Payer Mix Dynamics: Noted a slight increase in exchange volumes, but core commercial volumes were weaker, possibly due to macroeconomic factors.
• Contract Labor: Improvements attributed to renegotiated contracts and precision staffing strategies, with expectations to stabilize at pre-pandemic levels.
• M&A Activity: Continued discussions around joint ventures and acquisitions, with a disciplined approach to ensure strategic alignment and financial accretion.
• Medical Malpractice: Increased premiums in New Mexico due to legislative changes, with expectations for relief as new laws take effect.

Overall, Ardent Health showcased a strong start to 2026 with solid financial performance and strategic initiatives, while also navigating challenges related to volume trends and payer dynamics.